NCT03654950

Brief Summary

The overall aim with this study is to gain a deeper understanding of patient perceptions regarding empowerment in relation to a health platform.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 30, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 31, 2018

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

November 7, 2022

Status Verified

November 1, 2022

Enrollment Period

3.4 years

First QC Date

August 30, 2018

Last Update Submit

November 4, 2022

Conditions

Colorectal Cancer

Outcome Measures

Primary Outcomes (1)

  • Patient reported experiences in themes

    interview

    1 day

Secondary Outcomes (1)

  • Patient reported experiences divided into themes

    12 months

Interventions

No interventionOTHER

Interviews and questionnaires

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with colorectal cancer

You may qualify if:

  • Patient with colorectal cancer

You may not qualify if:

  • Inability to give informed consent or speaking and reading the Swedish language.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of Surgery, Sahlgrenska University Hospital/Ostra

Gothenburg, SE 416 85, Sweden

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Eva Angenete

    Sahlgrenska University Hospital and University of Gothenburg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor, consultant surgeon

Study Record Dates

First Submitted

August 30, 2018

First Posted

August 31, 2018

Study Start

June 1, 2018

Primary Completion

November 1, 2021

Study Completion

December 1, 2021

Last Updated

November 7, 2022

Record last verified: 2022-11

Locations

SE(1)